The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: A web-based survey and 2021 statement by Peritoneal Surface Oncology Group International (PSOGI)-Reference-Cited by-同舟云学术

The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: A web-based survey and 2021 statement by Peritoneal Surface Oncology Group International (PSOGI)

Published:2021-11 Issue:11 Volume:47 Page:2888-2892
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

van de Vlasakker Vincent C.J.,Lurvink Robin J.^ORCID,Cashin Peter H.^ORCID,Ceelen Wim^ORCID,Deraco Marcello^ORCID,Goéré Diane,González-Moreno Santiago^ORCID,Lehmann Kuno^ORCID,Li Yan,Moran Brendan,Morris David L.^ORCID,Piso Pompiliu^ORCID,Quadros Claudio A.^ORCID,Rau Beate,Somashekhar S.P.^ORCID,Sommariva Antonio^ORCID,van der Speeten Kurt,Spiliotis John,Sugarbaker Paul H.^ORCID,Teo Melissa C.C.,Verwaal Vic J.,Yonemura Yutaka,Glehen Olivier^ORCID,de Hingh Ignace H.J.T.

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference20 articles.

1. Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: a nationwide study;Lurvink;Eur J Surg Oncol,2020

2. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer;Verwaal;J Clin Oncol,2003

3. The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI);Bushati;Eur J Surg Oncol,2018

4. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial;Quenet;Lancet Oncol,2021

5. Autopsy of an expert consensus: end of hyperthermic intraperitoneal chemotherapy in colorectal carcinomatosis;Evrard;Eur J Surg Oncol,2018

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An observational cohort of patients with colorectal peritoneal metastases or pseudomyxoma peritonei treated with CRS-HIPEC: Development and first results of the Dutch CRS-HIPEC quality registry;European Journal of Surgical Oncology;2024-12

2. Systemic chemotherapy in addition to CRS‐HIPEC for colorectal peritoneal metastases: A critical systematic review on the impact on overall survival;Journal of Surgical Oncology;2024-09-11

3. First-line palliative systemic therapy alternated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: A single-arm phase II trial (CRC-PIPAC-II);European Journal of Surgical Oncology;2024-09

4. Is Hyperthermic Intraperitoneal Chemotherapy Appropriate for Colon Cancer?;Advances in Surgery;2024-09

5. The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: Pseudomyxoma Peritonei;Annals of Surgical Oncology;2024-07-15